|
James Huang - Entrepreneur in Residence, Vivo Ventures With 20 years of experience in the pharmaceutical industry, James joined Vivo Ventures from Anesiva, where he has served as president since September 2005. He joined Anesiva from Tularik Inc., where he held the position of vice president of business development and commercial operations. Prior to Tularik, Mr. Huang was product director of Avandia and diabetes at SmithKline Beecham PLC (now GlaxoSmithKline) where he launched Avandia. Mr. Huang also held various positions in Bristol-Myers Squibb's Worldwide Strategic Product Planning, Managed Care and Sales and Marketing organizations, and research and development positions at Alza Corporation. James received an M.B.A. from Stanford Graduate School of Business and earned a B.S. degree in Chemical Engineering at the University of California, Berkeley. | 